Replies to post #2363 on WINNERS CIRCLE!

[Depcom]

$PSTV
🧬 Due Diligence

Company: Plus Therapeutics Inc. (NASDAQ: PSTV)

Sector: Biotechnology (focus on cancer therapies)

Recent Catalysts:

Clinical trial results for a new cancer treatment
Strategic partnership with a major pharma company
Financial restructuring to improve cash flow

Technical Setup:
Recently crossed above 20-day moving average
Support: $0.32, $0.29
Resistance: $0.42, $0.50, $0.65

🔥 Short Interest & Float
Short Interest: 5.74 million shares
Short % of Float: 9.5%
Shares Outstanding: ~17 million
Float: ~14 million 2
Borrow Fee Rate: ~100%+ APR — very high, indicating strong short pressure and squeeze potential